11 October 2024 - Version 5 of the agenda for the November 2024 PBAC meeting is now available.

While there are four changes, there are only two major changes:

• IncobotulinumtoxinA (Xeomin) - submission has been withdrawn
• Rivaroxaban (Xarelto) - new sponsor

Read PBAC agenda